Trial Failure For NeoPharm
NeoPharm Inc. (NEOL) reported a failed trial for its experimental cancer treatment. The stock price plummeted $4.56 to close at $2.16.
posted by FC Market News at 10:59 AM
posted by FC Market News at 10:59 AM
0 Comments:
Post a Comment
<< Home